BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ronchi A, Montella M, Zito Marino F, Caraglia M, Grimaldi A, Argenziano G, Moscarella E, Brancaccio G, Troiani T, Napolitano S, Franco R, Cozzolino I. Predictive Evaluation on Cytological Sample of Metastatic Melanoma: The Role of BRAF Immunocytochemistry in the Molecular Era. Diagnostics (Basel) 2021;11:1110. [PMID: 34207125 DOI: 10.3390/diagnostics11061110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Belli V, Napolitano S, De Falco V, Suarato G, Perrone A, Guerrera LP, Martini G, Della Corte CM, Martinelli E, Morgillo F, Turano M, Furia M, Argenziano G, Ciardiello D, Ciardiello F, Troiani T. Targeting EphA2 and DDR signaling can overcome the BRAF and MEK inhibitors acquired resistance in melanoma cell lines. transl med commun 2023;8:3. [DOI: 10.1186/s41231-022-00133-5] [Reference Citation Analysis]
2 Belli V, Napolitano S, De Falco V, Suarato G, Perrone A, Guerrera LP, Martini G, Corte CMD, Martinelli E, Morgillo F, Turano M, Furia M, Argenziano G, Ciardiello D, Ciardiello F, Troiani T. Targeting EphA2 and DDR signaling can overcome the BRAF and MEK inhibitors acquired resistance in melanoma cell lines.. [DOI: 10.21203/rs.3.rs-2154654/v1] [Reference Citation Analysis]
3 Ronchi A, Zito Marino F, Moscarella E, Brancaccio G, Argenziano G, Troiani T, Napolitano S, Franco R, Cozzolino I. PRAME Immunocytochemistry for the Diagnosis of Melanoma Metastases in Cytological Samples. Diagnostics 2022;12:646. [DOI: 10.3390/diagnostics12030646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]